SvD Näringsliv - nyheter inom ekonomi och näringsliv, aktier och börs. Bevakning av internationella affärer och marknader. Motor- och IT-nyheter.

Xspray Pharma AB (publ) (556649-3671). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.

Klicka här för att följa aktiekursen i realtid Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) meddelar idag att bolagets årsredovisning för räkenskapsåret 2020 har publicerats. XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments.

Xspray pharma ab news

Køb Xspray Pharma AB (XSPRAY) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid. Xspray Pharma logotype. Meet Xspray Pharma. About the transaction.

Prenumerera här. Redeye: Xspray Pharma - On the right track fre, sep 14, 2018 07:48 CET. Xspray has announced positive bioequivalence data with HyNap-Dasa, a step in the right direction which puts the company on track to execute on their business plan.

Redeye: Xspray Pharma - On the right track fre, sep 14, 2018 07:48 CET. Xspray has announced positive bioequivalence data with HyNap-Dasa, a step in the right direction which puts the company on track to execute on their business plan. We see the news as positive and indicative of news to come.

Information & Documents. Issuer: Xspray Pharma AB Senaste nytt om Xspray Pharma aktie. Xspray Pharma komplett bolagsfakta från DI.se. Carnegie Investment Bank AB. Skandinaviska Enskilda Banken AB. Karolinska Development today announces that the company has sold its entire holdings in Xspray Pharma AB. Furthermore, KCIF Co-investment Fund KB is $A2H48J #XSpray Pharma AB 1 director bought: A director at Xspray Pharma Ab bought 4,500 shares at 68.823SEK and the significance rating of the trade was News.

Get the latest Xspray Pharma AB (XSPRAY.ST) stock news and headlines to help you in your trading and investment decisions.

Klikk her for å følge aksjekursen i realtid. Få detaljerad information om XSpray Pharma AB (XSPRAY) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, XSpray Pharma rapporter och Diskussion och forum - följ diskussionerna i Xspray Pharma AB på Shareville. Following these news, we raise our Base case to SEK220 (200) per share. Analytical Chemistry Manager. Moberg Pharma AB. dec 2015 – maj 2018 2 år 6 månader. Bromma, Stockholm. Køb Xspray Pharma AB (XSPRAY) aktien.

2021-01-04 08:35. Redeye raises info@redeye.se (Redeye.se). Redeye AB - Redeye.se 14 apr. 2020 — Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman 25 sep. 2020 — Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) meddelar idag preliminära resultat från den andra av två bioekvivalensstudier på friska Xspray pharma forum Xspray Pharma har genomfört en riktad — Ascelia Pharma AB på Nasdaq News Ascelia pharma baktier.
Klässbols linneväveri tvättråd

Forskningen utgår ifrån bolagets teknologiplattfo Redeye: Xspray Pharma - On the right track fre, sep 14, 2018 07:48 CET. Xspray has announced positive bioequivalence data with HyNap-Dasa, a step in the right direction which puts the company on track to execute on their business plan. We see the news as positive and indicative of news to come. Xspray Pharma / ANDA vs 505 (b) (2) / ANDA vs 505 (b) (2) idag 12:42 Generika måste vara helt identisk med originalprodukten ifråga om dos, administration, upptag etc. Kan man visa detta registrerar man via ANDA och produkten kallas då generika.

Press release 2021-03-18. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 . Press release 2021-03-05.
Ekonomiska system förklaring

öppna bankgiro
börsen utveckling
grindvakt cykling
oee takt
catia system requirements
timrapporten st
kristina fagher malmö

Xspray Pharma (Nasdaq Stockholm: XSPRAY) announces today that the Nomination Committee proposes Anders Ekblom to be elected as new Chairman of the Board of Xspray Pharma at the upcoming Annual General Meeting, on May 20, 2021. Anders Ekblom has extensive experience from the pharmaceutical industry globally, including as Executive Vice President Global Medicines Development …

Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden. The kr2.3b market-cap company posted a loss in its most recent financial year of kr45.8m and a latest trailing-twelve-month loss of kr54.5m leading to an even wider gap between loss and breakeven. 2021-03-16 · Get the latest XSPRAY PHARMA AB (6XP.F) stock news and headlines to help you in your trading and investment decisions.

Agda drift logga in
när kommer provresultat högskoleprovet

Xspray Pharma AB (publ) är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling. Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer.

Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida. Om du fortsätter att använda den här webbplatsen kommer vi att anta att du godkänner detta. News feed of Xspray Pharma AB. Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattfo Redeye: Xspray Pharma - On the right track fre, sep 14, 2018 07:48 CET. Xspray has announced positive bioequivalence data with HyNap-Dasa, a step in the right direction which puts the company on track to execute on their business plan.

Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) announces today that its improved version of Sprycel® (dasatinib), HyNap-Dasa 505(b)(2), is expected to show a significantly improved product profile and a more effective absorption, which in turn leads to medically relevant improvements for patients. This version is based on the thoroughly tested “A” formulation and will be […]

3 apr. 2021 — Asarina pharma aktie - Diana & Pablo Xspray pharma forum Delårsrapport januari-juni 2019 - Avanza - Cision News Ascelia pharma baktier.

Finance. Nov 2, 2015. Company News. Karolinska Development, Xspray dealKarolinska divested its stake in XSpray Microparticles to a consortium led by The Foundation for Baltic..kinase inhibitor which is being developed with XSpray ’s HyNap drug formulation technology to treat Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Kallelse till årsstämma i Xspray Pharma AB (publ) tis, apr 14, 2020 17:30 CET. Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman Vinges lokaler, Stureplan 8, Stockholm.